General Information of the Compound
| Compound ID |
CP0893107
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-oxetan-3-yl 4-(5-((3-cyanopyridin-4-yl)methoxy)pyrimidin-2-yl)-3-methylpiperazine-1-carboxylate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H22N6O4
|
||||||||||||||||||
| Molecular Weight |
410.434
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H]1CN(C(=O)OC2COC2)CCN1c1ncc(OCc2ccncc2C#N)cn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H22N6O4/c1-14-10-25(20(27)30-18-12-28-13-18)4-5-26(14)19-23-8-17(9-24-19)29-11-15-2-3-22-7-16(15)6-21/h2-3,7-9,14,18H,4-5,10-13H2,1H3/t14-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
JMXBXZHTVIADJO-CQSZACIVSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02455, Glucose-dependent insulinotropic receptor
Protein ID: PT02398, Glucose-dependent insulinotropic receptor